RWANDA COVID 19 HEALTH RESILIENCE

Promoter – Financial Intermediary

RWANDA BIOMEDICAL CENTRE

Location

• Rwanda

Description

The project will finance the reconstruction of the Rwanda Biomedical Centre (the Medical Technology Unit, the National Centre for Blood Transfusion, the National Reference Laboratory and the Research, Innovation & Data Science Division), and potentially other health interventions from the Rwanda COVID-19 National Response Plan.

Objectives

The operation's objective is to help the Government of Rwanda meet needs in the health sector directly related to the COVID-19 pandemic in line with the Government's "COVID-19 National Preparedness and Response Plan."

Sector(s)

• Health - Human health and social work activities

Under Global Europe NDICI guarantee

Under EFSD+ Guarantee

Proposed EIB finance (Approximate amount)

EUR 26 million

Total cost (Approximate amount)

EUR 27 million

Environmental aspects

The Bank will require the Promoter to ensure that the implementation of the project will be done in accordance with the Bank's Environmental and Social principles and standards. The Bank will require the project's compliance with the relevant environmental legislation and alignment of the Bank's Environmental and Social principles and standards. The Bank's services will assess the full environmental details during the project due diligence.

Procurement

The Bank will require the Promoter to ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.

Status

Signed - 29/09/2021